Government outlines health reform goals

July 20, 2010
NHS, NHS targets, government

The coalition government has proposed five areas, from increasing quality of life to preventing premature death, against which the success …

Manufacturing Q&A: Eden Biodesign

July 20, 2010
Business Services, Manufacturing and Production Eden Biodesign, careers, manufacturing

How long has your company been operating? Eden Biodesign is enjoying its tenth anniversary this year. How is your field …

J&J cited by FDA for another manufacturing facility

July 20, 2010
Manufacturing and Production J&J, JJ, manufacturing compliance

Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …

Excipient problem leads to Coumadin recall

July 20, 2010
Manufacturing and Production BMS, manufacturing compliance, recalls

Bristol-Myers Squibb is recalling nearly 150,000 tablets of its anticoagulant product Coumadin distributed across the US because some of them …

Pfizer forced to halt pain drug trials

July 20, 2010
Research and Development Pfizer, chronic pain, pain therapeutics, tanezumab

Pfizer has been told by the FDA to suspend trials of its novel injectable biotherapeutic tanezumab for chronic low back …

Manufacturing news in brief

July 20, 2010
Manufacturing and Production Apicore, Emergent, Merck & Co, PPS, Tianyin, lilly

A crop of facility announcements from Merck & Co, Emergent, Tianyin, Apicore and PPS offset more job loss news from …

Merck Millipore unveiled as $7bn acquisition completed

July 20, 2010
Manufacturing and Production Merck KGaA, Millipore

Germany’s Merck KGaA has completed its $7 billion acquisition of processing equipment specialist Millipore, officially launching the combined Merck Millipore …

Andy_Hayley

TBWAPaling Walters promotes Andy Hayley

July 20, 2010
Medical Communications TBWA/Paling Walters, appointment, medical communications

Health communications agency TBWA\Paling Walters has promoted former client services director Andy Hayley to managing director. He will succeed company …

Bayer signs Chinese research deal

July 20, 2010
Research and Development Bayer, China, gynaecology

Bayer is partnering with the People’s Liberation Army General Hospital in Beijing on research into women’s healthcare. The People’s Liberation …

EMA's new look website

Digital Pharma: Byte-sized roundup

July 19, 2010
Medical Communications Amgen, Digital Pharma blog, EMA, Sermo, digital doctors, google, psoriasis

This week’s roundup includes EMA’s new look website, a psoriasis patient group’s e-commerce venture, Amgen’s online patient empowerment competition, changes …

NICE’s methods to be put under the spotlight

July 19, 2010
Sales and Marketing MRC, NICE, cost-effectiveness

The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …

US approval for Sanofi’s Jevtana

July 19, 2010
Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer

US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …

Elan expects Zonegran marketing probe to cost it $206m

July 19, 2010
Sales and Marketing Elan, Zonegran

Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …

Matthew_Speers

UCB’s Speers to lead European Medicines Group

July 19, 2010
Sales and Marketing European Medicines Group, UCB, appointment, sales and marketing

UCB Pharma’s managing director Matthew Speers has been elected chair of the European Medicines Group, taking over from Nigel Brooksby …

NICE reaffirms positive opinion on Multaq

July 19, 2010
Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone

In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …

GSK takes £1.58bn hit from legal disputes

July 16, 2010
Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat

GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …

Lonza wins two biologic contracts

July 16, 2010
Manufacturing and Production Elusys, Human Genome Sciences, Lonza

Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …

UK pharma needs online pharmacovigilance guidance, says Digital Pioneer

July 16, 2010
Medical Communications Code of Practice, Sublime Digital, digital pharma

Pharma companies need more help from UK authorities on the issue of online pharmacovigilance, according to the winner of the …

Eisai collaborates on psychiatric disorder research

July 16, 2010
Research and Development Aestus Thereapeutics, Eisai

Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …

Changing business models top pharma concerns

July 16, 2010
Sales and Marketing Cegedim, industry, survey

The changing face of pharma business models is the main thing keeping US executives awake at night, according to a …

The Gateway to Local Adoption Series

Latest content